Top

Current Diabetes Reports

Published in:

01-09-2017 | Economics and Policy in Diabetes (ES Huang and AA Baig, Section Editors)

Academic and Government Partnerships to Address Diabetes in the USA: a Narrative Review

Authors: Stella S. Yi, Shadi Chamany, Lorna Thorpe

Published in: Current Diabetes Reports | Issue 9/2017

Abstract

Purpose of Review

Multi-sector partnerships are broadly considered to be of value for diabetes prevention and management. The purpose of this article is to summarize academic and government collaborations focused on diabetes prevention and management.

Recent Findings

Using a narrative review approach, we identified 17 articles describing 10 academic and government partnerships for diabetes management and surveillance. Challenges and gaps in the literature include complexity of diabetes management vis a vis current healthcare infrastructure; a paucity of racial/ethnic diversity in translational efforts; and the time/effort needed to maintain strong relationships across partner institutions.

Summary

Academic and government partnerships are of value for diabetes prevention and management activities. Acknowledgment that the key priorities of government programming are often costs and feasibility is critical for collaborations to be successful. Future translational efforts of diabetes prevention and management programs should focus on the following: (1) expansion of partnerships between academia and local health departments; (2) increased utilization of implementation science for enhanced and efficient implementation and dissemination; and (3) harnessing of technological advances for data analysis, patient communication, and report generation.

Available only for authorised users

Crude and age-adjusted incidence of diagnosed diabetes per 1,000 population aged 18–79 years, United States, 1980–2011. 2013. http://www.cdc.gov/diabetes/statistics/incidence/fig2.htm. Accessed Accessed Aug 26, 2014.

Geiss LS, Pan L, Cadwell B, Gregg EW, Benjamin SM, Engelgau MM. Changes in incidence of diabetes in U.S. adults, 1997-2003. Am J Prev Med. 2006;30(5):371–7. doi:10.1016/j.amepre.2005.12.009.CrossRefPubMed

American Diabetes A. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4):1033–46. doi:10.2337/dc12-2625.CrossRef

The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86. doi:10.1056/NEJM199309303291401.

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53.

UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703–13.

Cholesterol Treatment Trialists C, Kearney PM, Blackwell L, Collins R, Keech A, Simes J, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 2008;371(9607):117–25. doi:10.1016/S0140-6736(08)60104-X.CrossRef

Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89. doi:10.1056/NEJMoa0806470.CrossRefPubMed

Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest. 2007;131(2):446–52. doi:10.1378/chest.06-1587.CrossRefPubMed

10.

Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643–53. doi:10.1056/NEJMoa052187.CrossRefPubMed

11.

Centers for Disease Control and Prevention. National Diabetes Prevention Program. https://www.cdc.gov/diabetes/prevention/about/index.html. Accessed November 9, 2016.

12.

Albright AL, Gregg EW. Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program. Am J Prev Med. 2013;44(4 Suppl 4):S346–51. doi:10.1016/j.amepre.2012.12.009.CrossRefPubMedPubMedCentral

13.

Vojta D, Koehler TB, Longjohn M, Lever JA, Caputo NF. A coordinated national model for diabetes prevention: linking health systems to an evidence-based community program. Am J Prev Med. 2013;44(4 Suppl 4):S301–6. doi:10.1016/j.amepre.2012.12.018.CrossRefPubMed

14.

Centers for Disease Control and Prevention. National Diabetes Prevention Program. Registry of Recognized Organizations. https://nccd.cdc.gov/DDT_DPRP/Registry.aspx. Accessed March 28, 2017.

15.

Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med. 2013;368(17):1613–24. doi:10.1056/NEJMsa1213829.CrossRefPubMed

16.

Lenfant C. Shattuck lecture—clinical research to clinical practice—lost in translation? N Engl J Med. 2003;349(9):868–74. doi:10.1056/NEJMsa035507.CrossRefPubMed

17.

Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff. 2012;31(1):67–75. doi:10.1377/hlthaff.2011.1009.CrossRef

18.

Tabak RG, Sinclair KA, Baumann AA, Racette SB, Sebert Kuhlmann A, Johnson-Jennings MD, et al. A review of diabetes prevention program translations: use of cultural adaptation and implementation research. Transl Behav Med. 2015;5(4):401–14. doi:10.1007/s13142-015-0341-0.CrossRefPubMedPubMedCentral

19.

Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50. doi:10.1186/1748-5908-4-50.CrossRefPubMedPubMedCentral

20.

Institute of Medicine. The Future of the Public’s Health in the 21st Century. Washington, DC2002.

21.

Keck CW. Lessons learned from an academic health department. J Public Health Manag Pract. 2000;6(1):47–52.CrossRefPubMed

22.

Livingood WC, Goldhagen J, Little WL, Gornto J, Hou T. Assessing the status of partnerships between academic institutions and public health agencies. Am J Public Health. 2007;97(4):659–66. doi:10.2105/AJPH.2005.083188.CrossRefPubMedPubMedCentral

23.

• Neri EM, Ballman MR, Lu H, Greenlund KJ, Grunbaum JA. Academic-health department collaborative relationships are reciprocal and strengthen public health practice: results from a study of academic research centers. J Public Health Manag Pract. 2014;20(3):342–8. doi:10.1097/PHH.0b013e3182a152c6. Provides helpful background on the CDC Prevention Research Center program—which fosters collaborations between academia and local health departments. CrossRefPubMed

24.

Erwin PC, Barlow P, Brownson RC, Amos K, Keck CW. Characteristics of academic health departments: initial findings from a cross-sectional survey. J Public Health Manag Pract. 2016;22(2):190–3. doi:10.1097/phh.0000000000000237.CrossRefPubMedPubMedCentral

25.

A unique partnership: The University at Albany’s School of Public Health and New York State Department of Health. http://www.albany.edu/healthsciences/ualbany-nysdoh-partnership.php. Accessed March 30, 2017.

26.

Public Health Foundation. Academic Health Department Partnership Agreements. http://www.phf.org/resourcestools/Pages/AHD_Partnership_Agreements.aspx. Accessed March 30, 2017.

27.

Chin MH, Goddu AP, Ferguson MJ, Peek ME. Expanding and sustaining integrated health care—community efforts to reduce diabetes disparities. Health Promot Pract. 2014;15(2 Suppl):29S–39S. doi:10.1177/1524839914532649.CrossRefPubMedPubMedCentral

28.

Peek ME, Ferguson M, Bergeron N, Maltby D, Chin MH. Integrated community-healthcare diabetes interventions to reduce disparities. Curr Diab Rep. 2014;14(3):467. doi:10.1007/s11892-013-0467-8.CrossRefPubMedPubMedCentral

29.

Norris SL, Chowdhury FM, Van Le K, Horsley T, Brownstein JN, Zhang X, et al. Effectiveness of community health workers in the care of persons with diabetes. Diabet Med. 2006;23(5):544–56. doi:10.1111/j.1464-5491.2006.01845.x.CrossRefPubMed

30.

Palmas W, March D, Darakjy S, Findley SE, Teresi J, Carrasquillo O, et al. Community health worker interventions to improve glycemic control in people with diabetes: a systematic review and meta-analysis. J Gen Intern Med. 2015;30(7):1004–12. doi:10.1007/s11606-015-3247-0.CrossRefPubMedPubMedCentral

31.

Shah M, Kaselitz E, Heisler M. The role of community health workers in diabetes: update on current literature. Curr Diab Rep. 2013;13(2):163–71. doi:10.1007/s11892-012-0359-3.CrossRefPubMedPubMedCentral

32.

Stellefson M, Dipnarine K, Stopka C. The chronic care model and diabetes management in US primary care settings: a systematic review. Prev Chronic Dis. 2013;10:E26. doi:10.5888/pcd10.120180.CrossRefPubMedPubMedCentral

33.

Baumeister RF, Leary MR. Writing narrative literature reviews. Rev Gen Psychol. 1997;1(3):311–20. doi:10.1037/1089-2680.1.3.311.CrossRef

34.

Paul MM, Greene CM, Newton-Dame R, Thorpe LE, Perlman SE, McVeigh KH, et al. The state of population health surveillance using electronic health records: a narrative review. Popul Health Manag. 2015;18(3):209–16. doi:10.1089/pop.2014.0093.CrossRefPubMed

35.

Lopez PM, Islam N, Feinberg A, Myers C, Seidl L., Drackett E et al., 2015. Am J Prev Med. 2016; In press.

36.

Dearinger AT, Ingram RC, Pendley RP, Wilding S. Diabetes education: quality improvement interventions through health departments. Am J Prev Med. 2013;45(6):782–6. doi:10.1016/j.amepre.2013.08.007.CrossRefPubMedPubMedCentral

37.

Walker EA, Silver LD, Chamany S, Schechter CB, Gonzalez JS, Carrasco J, et al. Baseline characteristics and Latino versus non-Latino contrasts among Bronx A1C study participants. West J Nurs Res. 2014;36(9):1030–51. doi:10.1177/0193945913517947.CrossRefPubMedPubMedCentral

38.

Chamany S, Silver LD, Bassett MT, Driver CR, Berger DK, Neuhaus CE, et al. Tracking diabetes: New York City’s A1C Registry. Milbank Q. 2009;87(3):547–70. doi:10.1111/j.1468-0009.2009.00568.x.CrossRefPubMedPubMedCentral

39.

Chamany S, Walker EA, Schechter CB, Gonzalez JS, Davis NJ, Ortega FM, et al. Telephone intervention to improve diabetes control: a randomized trial in the New York City A1c Registry. Am J Prev Med. 2015;49(6):832–41. doi:10.1016/j.amepre.2015.04.016.CrossRefPubMedPubMedCentral

40.

•• Ackermann RT, Kenrik Duru O, Albu JB, Schmittdiel JA, Soumerai SB, Wharam JF, et al. Evaluating diabetes health policies using natural experiments: the natural experiments for translation in diabetes study. Am J Prev Med. 2015;48(6):747–54. doi:10.1016/j.amepre.2014.12.010. Describes newest efforts at the adoption of multi-sector collaborative natural experiments for diabetes prevention and management. CrossRefPubMedPubMedCentral

41.

Jenkins C, McNary S, Carlson BA, King MG, Hossler CL, Magwood G, et al. Reducing disparities for African Americans with diabetes: progress made by the REACH 2010 Charleston and Georgetown Diabetes Coalition. Public Health Rep. 2004;119(3):322–30. doi:10.1016/j.phr.2004.04.011.CrossRefPubMedPubMedCentral

42.

Centers for Disease Control and Prevention, Division of Community Health, Racial and Ethnic Approaches to Community Health (REACH). https://www.cdc.gov/nccdphp/dch/programs/reach/. Accessed February 24, 2017.

43.

REACH Detroit Partnership. http://www.reachdetroit.org/. Accessed February 24, 2017.

44.

Spencer MS, Rosland AM, Kieffer EC, Sinco BR, Valerio M, Palmisano G, et al. Effectiveness of a community health worker intervention among African American and Latino adults with type 2 diabetes: a randomized controlled trial. Am J Public Health. 2011;101(12):2253–60. doi:10.2105/AJPH.2010.300106.CrossRefPubMedPubMedCentral

45.

Two Feathers J, Kieffer EC, Palmisano G, Anderson M, Sinco B, Janz N, et al. Racial and Ethnic Approaches to Community Health (REACH) Detroit partnership: improving diabetes-related outcomes among African American and Latino adults. Am J Public Health. 2005;95(9):1552–60. doi:10.2105/AJPH.2005.066134.CrossRefPubMedPubMedCentral

46.

McClellan L, Schlundt D. Overview of Nashville REACH 2010’s approach to eliminating disparities in diabetes and cardiovascular disease. J Ambul Care Manage. 2006;29(2):106–11.CrossRefPubMed

47.

Schlundt DG, Greene C, Reid R, McClellan L, Dowling L, Sheats JL, et al. An evaluation of the Nashville REACH 2010 community health screening strategy. J Ambul Care Manage. 2006;29(2):151–61.CrossRefPubMed

48.

Centers for Disease Control and Prevention, Division of Community Health, REACH 2014 Awardees. https://www.cdc.gov/nccdphp/dch/programs/reach/current_programs/reach.html. Accessed February 24, 2017.

49.

Thorpe LE KR, Chamany S, Chernov C, Freeman A, Gupta L, Frankel M, Perlman S., editor. Change in diabetes prevalence and control in New York City adults: population-based examination surveys, 2004–2014. Epidemiology Congress of the Americas 2016; June 21–24, 2016; Miami FL.

50.

New York City Department of Health and Mental Hygiene. The NYC Macroscope. https://www1.nyc.gov/site/doh/data/health-tools/nycmacroscope.page. Accessed June 30, 2016.

51.

Thorpe LE, McVeigh KH, Perlman S, Chan PY, Bartley K, Schreibstein L, et al. Monitoring prevalence, treatment, and control of metabolic conditions in New York City adults using 2013 primary care electronic health records: a surveillance validation study. EGEMS (Wash DC). 2016;4(1):1266. doi:10.13063/2327-9214.1266.

52.

Jones R, Maene C, M. P., Huang E, editors. Use of Dasymetric Areal Interpolation to Estimate the Burden of Diabetes Hospitalization in Chicago Neighborhoods. https://cste.confex.com/cste/2013/webprogram/Paper1712.html. Annual Conference of the Council of State and Territorial Epidemiologists; 2013; Pasadena, CA.

53.

Simon PA, Wold CM, Cousineau MR, Fielding JE. Meeting the data needs of a local health department: the Los Angeles County Health Survey. Am J Public Health. 2001;91(12):1950–2.CrossRefPubMedPubMedCentral

54.

Hosler AS, Zeinomar N, Asare K. Diabetes-related services and programs in small local public health departments, 2009-2010. Prev Chronic Dis. 2012;9:E07.PubMed

55.

Curtis AB, Kothari C, Paul R, Connors E. Using GIS and secondary data to target diabetes-related public health efforts. Public Health Rep. 2013;128(3):212–20. doi:10.1177/003335491312800311.CrossRefPubMedPubMedCentral

56.

Drewnowski A, Rehm CD, Moudon AV, Arterburn D. The geography of diabetes by census tract in a large sample of insured adults in King County, Washington, 2005-2006. Prev Chronic Dis. 2014;11:E125. doi:10.5888/pcd11.140135.CrossRefPubMedPubMedCentral

57.

Eggleston EM, Weitzman ER. Innovative uses of electronic health records and social media for public health surveillance. Curr Diab Rep. 2014;14(3):468. doi:10.1007/s11892-013-0468-7.CrossRefPubMed

58.

Lee DC, Long JA, Wall SP, Carr BG, Satchell SN, Braithwaite RS, et al. Determining chronic disease prevalence in local populations using emergency department surveillance. Am J Public Health. 2015;105(9):e67–74. doi:10.2105/AJPH.2015.302679.CrossRefPubMedPubMedCentral

59.

Chesla CA, Chun KM, Kwong Y, Gay CL, Chi HL, Gu Y, et al. Cultural adaptation of the group lifestyle balance program for Chinese Americans. Diabetes Educ. 2016;42(6):686–96. doi:10.1177/0145721716666679.CrossRefPubMed

60.

Hall DL, Lattie EG, McCalla JR, Saab PG. Translation of the diabetes prevention program to ethnic communities in the United States. J Immigr Minor Health. 2016;18(2):479–89. doi:10.1007/s10903-015-0209-x.CrossRefPubMed

61.

Islam NS, Zanowiak JM, Wyatt LC, Chun K, Lee L, Kwon SC, et al. A randomized-controlled, pilot intervention on diabetes prevention and healthy lifestyles in the new York City Korean community. J Community Health. 2013;38(6):1030–41. doi:10.1007/s10900-013-9711-z.CrossRefPubMedPubMedCentral

62.

Islam NS, Zanowiak JM, Wyatt LC, Kavathe R, Singh H, Kwon SC, et al. Diabetes prevention in the New York City Sikh Asian Indian community: a pilot study. Int J Environ Res Public Health. 2014;11(5):5462–86. doi:10.3390/ijerph110505462.CrossRefPubMedPubMedCentral

63.

O'Brien MJ, Perez A, Alos VA, Whitaker RC, Ciolino JD, Mohr DC, et al. The feasibility, acceptability, and preliminary effectiveness of a Promotora-Led Diabetes Prevention Program (PL-DPP) in Latinas: a pilot study. Diabetes Educ. 2015;41(4):485–94. doi:10.1177/0145721715586576.CrossRefPubMedPubMedCentral

64.

Perez A, Alos VA, Scanlan A, Maia CM, Davey A, Whitaker RC, et al. The rationale, design, and baseline characteristics of PREVENT-DM: a community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes. Contemp Clin Trials. 2015;45(Pt B):320–7. doi:10.1016/j.cct.2015.10.011.CrossRefPubMedPubMedCentral

65.

Rosas LG, Vasquez JJ, Naderi R, Jeffery N, Hedlin H, Qin F, et al. Development and evaluation of an enhanced diabetes prevention program with psychosocial support for urban American Indians and Alaska natives: a randomized controlled trial. Contemp Clin Trials. 2016;50:28–36. doi:10.1016/j.cct.2016.06.015.CrossRefPubMed

66.

Van Name MA, Camp AW, Magenheimer EA, Li F, Dziura JD, Montosa A, et al. Effective translation of an intensive lifestyle intervention for Hispanic women with prediabetes in a community health center setting. Diabetes Care. 2016;39(4):525–31. doi:10.2337/dc15-1899.CrossRefPubMedPubMedCentral

67.

Williams LB, Sattin RW, Dias J, Garvin JT, Marion L, Joshua T, et al. Design of a cluster-randomized controlled trial of a diabetes prevention program within African-American churches: The fit body and soul study. Contemp Clin Trials. 2013;34(2):336–47. doi:10.1016/j.cct.2013.01.002.CrossRefPubMedPubMedCentral

68.

Yeh MC, Heo M, Suchday S, Wong A, Poon E, Liu G, et al. Translation of the diabetes prevention program for diabetes risk reduction in Chinese immigrants in New York City. Diabet Med. 2016;33(4):547–51. doi:10.1111/dme.12848.CrossRefPubMed

69.

Shah GH, Sheahan JP. Local health departments’ activities to address health disparities and inequities: are we moving in the right direction? Int J Environ Res Public Health. 2015;13(1) doi:10.3390/ijerph13010044.

70.

Glasgow RE, Vinson C, Chambers D, Khoury MJ, Kaplan RM, Hunter C. National Institutes of Health approaches to dissemination and implementation science: current and future directions. Am J Public Health. 2012;102(7):1274–81. doi:10.2105/AJPH.2012.300755.CrossRefPubMedPubMedCentral

71.

Tung EL, Peek ME. Linking community resources in diabetes care: a role for technology? Curr Diab Rep. 2015;15(7):45. doi:10.1007/s11892-015-0614-5.CrossRefPubMed

72.

Ahmad FS, Tsang T. Diabetes prevention, health information technology, and meaningful use: challenges and opportunities. Am J Prev Med. 2013;44(4 Suppl 4):S357–63. doi:10.1016/j.amepre.2012.12.020.CrossRefPubMed

73.

Ruddock JS, Poindexter M, Gary-Webb TL, Walker EA, Davis NJ. Innovative strategies to improve diabetes outcomes in disadvantaged populations. Diabet Med. 2016;33(6):723–33. doi:10.1111/dme.13088.CrossRefPubMed

74.

Bouchonville MF, Paul MM, Billings J, Kirk JB, Arora S. Taking telemedicine to the next level in diabetes population management: a review of the Endo echo model. Curr Diab Rep. 2016;16(10):96. doi:10.1007/s11892-016-0784-9.CrossRefPubMed

75.

Hood M, Wilson R, Corsica J, Bradley L, Chirinos D, Vivo A. What do we know about mobile applications for diabetes self-management? A review of reviews. J Behav Med. 2016;39(6):981–94. doi:10.1007/s10865-016-9765-3.CrossRefPubMed

Title: Academic and Government Partnerships to Address Diabetes in the USA: a Narrative Review
Authors: Stella S. Yi
Shadi Chamany
Lorna Thorpe
Publication date: 01-09-2017
Publisher: Springer US
Published in: Current Diabetes Reports / Issue 9/2017
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-017-0895-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 9/2017

Process-Based Treatment of Diabetes in Kaiser Permanente Southern California: How to Make Diabetes Care “Complete”

Cardiovascular Outcome Trial Update in Diabetes: New Evidence, Remaining Questions

A Scoping Review of Behavioral Economic Interventions for Prevention and Treatment of Type 2 Diabetes Mellitus

Cigarette Smoking, Diabetes, and Diabetes Complications: Call for Urgent Action

Immunological Issues After Stem Cell-Based β Cell Replacement

Remote Monitoring and Consultation of Inpatient Populations with Diabetes

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage